Replay past webinars.

Treatment considerations for DPP-4 inhibitors in T2D:
a simple solution for a long-term outlook?

Watch the video:

Dr Xavier Cos

Barcelona, Spain

  • President of Primary Care Diabetes Europe (PCDE)
  • Director of Sant Marti de Provençals Clinical trials Unit
  • Associate Professor of Medicine, Universitat Autonoma de Barcelona, Spain

Dr. Cos is a general practitioner with a specific interest in primary prevention of diabetes, improving the quality of diabetes management and clinical trials of glucose-lowering therapies.

Dr Miguel A.

Madrid, Spain

  • Endocrinologist at Hospital Universitario Puerta de Hierro
  • Assistant Professor in Endocrinology, Universidad Autónoma de Madrid, Spain

Dr. Miguel A. Brito-Sanfiel is an endocrinologist whose research focusses on the efficacy and safety of glucose-lowering therapies and the effect of hypercholesterolemia, obesity and diet on the development of diabetes.

How did you like this page?

Average: 5 (3 votes)